Cervical cancer screening is as important in female‐to‐male transgender (FTMT) patients as it is in cisgender female patients. The aim of this study was to examine the impact of clinical… Click to show full abstract
Cervical cancer screening is as important in female‐to‐male transgender (FTMT) patients as it is in cisgender female patients. The aim of this study was to examine the impact of clinical information regarding gender identity and testosterone therapy on the cytological interpretations.
               
Click one of the above tabs to view related content.